| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Blood Glucose | 115 | 2023 | 1123 | 4.430 |
Why?
|
| Insulin | 109 | 2021 | 1208 | 4.240 |
Why?
|
| Gluconeogenesis | 28 | 2020 | 108 | 3.830 |
Why?
|
| Lactation | 15 | 2020 | 188 | 3.460 |
Why?
|
| Glucose | 56 | 2021 | 880 | 3.340 |
Why?
|
| Leucine | 59 | 2006 | 310 | 2.730 |
Why?
|
| Diabetes Mellitus, Type 1 | 29 | 2017 | 798 | 2.730 |
Why?
|
| Hypoglycemia | 29 | 2017 | 191 | 2.690 |
Why?
|
| Glucagon | 52 | 2017 | 185 | 2.640 |
Why?
|
| Milk, Human | 11 | 2022 | 301 | 2.330 |
Why?
|
| Insulin Resistance | 23 | 2021 | 644 | 2.240 |
Why?
|
| Hypoglycemic Agents | 17 | 2023 | 429 | 1.780 |
Why?
|
| Galactose | 6 | 2015 | 54 | 1.760 |
Why?
|
| Mammary Glands, Human | 5 | 2015 | 79 | 1.680 |
Why?
|
| Diabetes Mellitus, Type 2 | 18 | 2024 | 1237 | 1.570 |
Why?
|
| Hyperglycemia | 18 | 2018 | 222 | 1.450 |
Why?
|
| Fasting | 32 | 2018 | 300 | 1.430 |
Why?
|
| Human Growth Hormone | 8 | 2016 | 74 | 1.400 |
Why?
|
| Dietary Carbohydrates | 8 | 2014 | 118 | 1.360 |
Why?
|
| Carbon Isotopes | 19 | 2015 | 277 | 1.260 |
Why?
|
| Proteins | 23 | 2006 | 1040 | 1.190 |
Why?
|
| Lipodystrophy | 3 | 2023 | 34 | 1.150 |
Why?
|
| Growth Hormone | 29 | 2005 | 153 | 1.140 |
Why?
|
| Insulin-Like Growth Factor I | 12 | 2011 | 342 | 1.040 |
Why?
|
| C-Peptide | 18 | 2023 | 113 | 0.970 |
Why?
|
| Glycogenolysis | 3 | 2018 | 10 | 0.950 |
Why?
|
| Lactose | 4 | 2020 | 54 | 0.920 |
Why?
|
| Amyloid | 4 | 2009 | 64 | 0.910 |
Why?
|
| Keto Acids | 29 | 1993 | 56 | 0.900 |
Why?
|
| Hormones | 9 | 2017 | 190 | 0.880 |
Why?
|
| Obesity | 18 | 2022 | 2235 | 0.870 |
Why?
|
| Kinetics | 45 | 2009 | 1317 | 0.870 |
Why?
|
| Leptin | 2 | 2023 | 214 | 0.860 |
Why?
|
| Fructose | 5 | 2009 | 62 | 0.810 |
Why?
|
| Humans | 244 | 2024 | 123259 | 0.810 |
Why?
|
| Adult | 110 | 2024 | 29100 | 0.770 |
Why?
|
| Glutamine | 15 | 2015 | 207 | 0.760 |
Why?
|
| Female | 157 | 2024 | 65617 | 0.760 |
Why?
|
| Prednisone | 11 | 2009 | 274 | 0.760 |
Why?
|
| Models, Biological | 14 | 2015 | 1450 | 0.750 |
Why?
|
| Glycolipids | 3 | 2011 | 33 | 0.750 |
Why?
|
| Dietary Fats | 5 | 2013 | 296 | 0.750 |
Why?
|
| Glycerol | 13 | 2015 | 91 | 0.750 |
Why?
|
| Bariatric Surgery | 2 | 2020 | 116 | 0.740 |
Why?
|
| Adolescent | 71 | 2024 | 19127 | 0.700 |
Why?
|
| Breast Feeding | 5 | 2020 | 220 | 0.670 |
Why?
|
| Homeostasis | 13 | 2012 | 683 | 0.670 |
Why?
|
| Energy Metabolism | 12 | 2012 | 774 | 0.670 |
Why?
|
| Eating | 11 | 2014 | 373 | 0.660 |
Why?
|
| Triglycerides | 8 | 2014 | 562 | 0.640 |
Why?
|
| Glycoproteins | 3 | 2011 | 369 | 0.630 |
Why?
|
| Amino Acids | 31 | 2003 | 663 | 0.630 |
Why?
|
| Lipid Metabolism | 5 | 2010 | 350 | 0.620 |
Why?
|
| Fatty Acids, Nonesterified | 25 | 2009 | 136 | 0.620 |
Why?
|
| Oxidation-Reduction | 26 | 2009 | 444 | 0.620 |
Why?
|
| Insulin Infusion Systems | 7 | 2017 | 61 | 0.600 |
Why?
|
| Diabetic Ketoacidosis | 5 | 2015 | 154 | 0.600 |
Why?
|
| Islets of Langerhans | 7 | 2013 | 173 | 0.590 |
Why?
|
| Ketone Bodies | 27 | 2009 | 47 | 0.590 |
Why?
|
| Carbon Radioisotopes | 24 | 1997 | 71 | 0.590 |
Why?
|
| Glucose Tolerance Test | 13 | 2016 | 209 | 0.570 |
Why?
|
| Male | 141 | 2024 | 60334 | 0.560 |
Why?
|
| Milk Proteins | 2 | 2011 | 92 | 0.560 |
Why?
|
| Fatty Acids | 10 | 2020 | 338 | 0.560 |
Why?
|
| Dietary Sucrose | 2 | 2010 | 41 | 0.550 |
Why?
|
| Lipids | 4 | 2013 | 513 | 0.540 |
Why?
|
| Gastrointestinal Agents | 2 | 2016 | 60 | 0.540 |
Why?
|
| Adipose Tissue | 8 | 2023 | 465 | 0.510 |
Why?
|
| Fluid Therapy | 2 | 2015 | 121 | 0.510 |
Why?
|
| Brain Edema | 2 | 2015 | 69 | 0.500 |
Why?
|
| Cross-Over Studies | 10 | 2020 | 311 | 0.500 |
Why?
|
| Child | 72 | 2024 | 24256 | 0.490 |
Why?
|
| Ghrelin | 2 | 2012 | 54 | 0.480 |
Why?
|
| Autoantibodies | 3 | 2013 | 427 | 0.480 |
Why?
|
| Liver | 23 | 2018 | 1743 | 0.470 |
Why?
|
| Diabetes, Gestational | 2 | 2014 | 109 | 0.460 |
Why?
|
| Metformin | 6 | 2023 | 147 | 0.460 |
Why?
|
| Injections, Subcutaneous | 12 | 2016 | 126 | 0.460 |
Why?
|
| Gene Expression Regulation | 3 | 2013 | 2525 | 0.450 |
Why?
|
| Lipogenesis | 1 | 2014 | 59 | 0.440 |
Why?
|
| Postprandial Period | 3 | 2009 | 77 | 0.440 |
Why?
|
| Breast | 2 | 2007 | 214 | 0.430 |
Why?
|
| Insulin-Secreting Cells | 2 | 2012 | 147 | 0.430 |
Why?
|
| Early Medical Intervention | 1 | 2013 | 30 | 0.420 |
Why?
|
| Glutamate Decarboxylase | 1 | 2013 | 36 | 0.420 |
Why?
|
| Child Welfare | 1 | 2013 | 66 | 0.410 |
Why?
|
| Uridine Diphosphate Galactose | 1 | 2012 | 6 | 0.410 |
Why?
|
| Early Diagnosis | 1 | 2013 | 179 | 0.400 |
Why?
|
| Body Mass Index | 8 | 2018 | 1553 | 0.400 |
Why?
|
| Fibrinogen | 5 | 1993 | 152 | 0.400 |
Why?
|
| Dogs | 30 | 1993 | 764 | 0.390 |
Why?
|
| Evidence-Based Medicine | 1 | 2015 | 623 | 0.380 |
Why?
|
| Growth Disorders | 2 | 2013 | 208 | 0.380 |
Why?
|
| Tritium | 14 | 1995 | 173 | 0.380 |
Why?
|
| Lactic Acid | 9 | 2015 | 147 | 0.370 |
Why?
|
| Metabolism | 3 | 2012 | 42 | 0.370 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2012 | 187 | 0.370 |
Why?
|
| Protein Biosynthesis | 11 | 2006 | 665 | 0.370 |
Why?
|
| Alanine | 22 | 2002 | 181 | 0.370 |
Why?
|
| Oligosaccharides | 2 | 2022 | 76 | 0.370 |
Why?
|
| Recombinant Proteins | 13 | 2015 | 1385 | 0.370 |
Why?
|
| Puberty | 7 | 2020 | 94 | 0.360 |
Why?
|
| Blood Chemical Analysis | 3 | 2021 | 78 | 0.350 |
Why?
|
| Deuterium Oxide | 2 | 2020 | 17 | 0.340 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 9 | 2008 | 77 | 0.340 |
Why?
|
| Biomedical Research | 1 | 2015 | 517 | 0.340 |
Why?
|
| Gastric Emptying | 2 | 2008 | 78 | 0.320 |
Why?
|
| Diet | 7 | 2020 | 1136 | 0.320 |
Why?
|
| Epithelial Cells | 1 | 2013 | 902 | 0.310 |
Why?
|
| Deuterium | 14 | 2002 | 109 | 0.310 |
Why?
|
| Caloric Restriction | 1 | 2009 | 85 | 0.310 |
Why?
|
| Glucocorticoids | 5 | 2009 | 378 | 0.310 |
Why?
|
| Serum Albumin | 5 | 2003 | 109 | 0.310 |
Why?
|
| Lipolysis | 5 | 2020 | 82 | 0.300 |
Why?
|
| Blood Glucose Self-Monitoring | 5 | 2019 | 113 | 0.290 |
Why?
|
| Hyperinsulinism | 6 | 2002 | 68 | 0.290 |
Why?
|
| Child, Preschool | 40 | 2017 | 13918 | 0.290 |
Why?
|
| Suction | 1 | 2007 | 58 | 0.290 |
Why?
|
| Time Factors | 21 | 2013 | 6223 | 0.280 |
Why?
|
| Body Composition | 7 | 2005 | 516 | 0.270 |
Why?
|
| Radioactive Tracers | 1 | 2006 | 21 | 0.270 |
Why?
|
| Gene Expression | 2 | 2011 | 1566 | 0.270 |
Why?
|
| Gene Expression Profiling | 3 | 2013 | 1682 | 0.270 |
Why?
|
| Food | 3 | 2003 | 125 | 0.270 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2007 | 141 | 0.270 |
Why?
|
| Blood Specimen Collection | 1 | 2006 | 47 | 0.260 |
Why?
|
| Weight Loss | 2 | 2009 | 481 | 0.260 |
Why?
|
| Diabetes Mellitus | 8 | 2013 | 850 | 0.260 |
Why?
|
| Isoleucine | 5 | 1991 | 27 | 0.260 |
Why?
|
| Hydrocortisone | 17 | 1993 | 220 | 0.260 |
Why?
|
| Pediatric Obesity | 3 | 2024 | 384 | 0.260 |
Why?
|
| Dose-Response Relationship, Drug | 8 | 2016 | 1689 | 0.250 |
Why?
|
| Glycogen | 3 | 2002 | 63 | 0.250 |
Why?
|
| Microarray Analysis | 3 | 2012 | 232 | 0.250 |
Why?
|
| Infusions, Intravenous | 11 | 2015 | 539 | 0.240 |
Why?
|
| Energy Intake | 7 | 2018 | 490 | 0.240 |
Why?
|
| Islet Amyloid Polypeptide | 4 | 2009 | 11 | 0.240 |
Why?
|
| Chromatography, High Pressure Liquid | 11 | 1993 | 339 | 0.240 |
Why?
|
| Lipid Droplets | 3 | 2011 | 46 | 0.230 |
Why?
|
| Reference Values | 15 | 2002 | 701 | 0.230 |
Why?
|
| Caprylates | 3 | 1991 | 12 | 0.220 |
Why?
|
| Animals | 43 | 2021 | 33850 | 0.220 |
Why?
|
| Epinephrine | 17 | 2003 | 175 | 0.220 |
Why?
|
| Calorimetry, Indirect | 5 | 2009 | 60 | 0.220 |
Why?
|
| Parenteral Nutrition | 6 | 1996 | 187 | 0.220 |
Why?
|
| Hydroxybutyrates | 15 | 1992 | 44 | 0.220 |
Why?
|
| Lactates | 19 | 2009 | 93 | 0.210 |
Why?
|
| Phenylbutyrates | 2 | 2006 | 58 | 0.210 |
Why?
|
| Infant | 24 | 2022 | 12376 | 0.210 |
Why?
|
| Reproducibility of Results | 6 | 2008 | 2844 | 0.200 |
Why?
|
| Receptors, Ghrelin | 2 | 2012 | 29 | 0.200 |
Why?
|
| Diabetic Nephropathies | 1 | 2023 | 111 | 0.200 |
Why?
|
| Nutritional Physiological Phenomena | 2 | 2000 | 93 | 0.200 |
Why?
|
| Glycomics | 1 | 2021 | 16 | 0.190 |
Why?
|
| Biosynthetic Pathways | 1 | 2021 | 25 | 0.190 |
Why?
|
| Spleen | 1 | 2002 | 272 | 0.190 |
Why?
|
| Isotope Labeling | 6 | 2009 | 105 | 0.190 |
Why?
|
| Monitoring, Physiologic | 3 | 2013 | 364 | 0.190 |
Why?
|
| Adolescent Development | 2 | 2013 | 26 | 0.180 |
Why?
|
| Carbon Dioxide | 6 | 2000 | 273 | 0.180 |
Why?
|
| Phenylalanine | 2 | 1993 | 124 | 0.180 |
Why?
|
| Acidosis | 4 | 1989 | 94 | 0.180 |
Why?
|
| Glycogen Storage Disease Type I | 3 | 1986 | 11 | 0.180 |
Why?
|
| 3-Hydroxybutyric Acid | 11 | 2002 | 26 | 0.180 |
Why?
|
| Receptor, Insulin | 3 | 2020 | 67 | 0.180 |
Why?
|
| Blood Proteins | 4 | 1999 | 116 | 0.180 |
Why?
|
| Kidney | 6 | 2015 | 1342 | 0.180 |
Why?
|
| Adiposity | 2 | 2014 | 191 | 0.180 |
Why?
|
| Polysaccharides | 1 | 2021 | 143 | 0.180 |
Why?
|
| Biochemistry | 1 | 2000 | 11 | 0.180 |
Why?
|
| Reye Syndrome | 7 | 1989 | 10 | 0.180 |
Why?
|
| Bodily Secretions | 1 | 2020 | 7 | 0.170 |
Why?
|
| Incretins | 1 | 2020 | 25 | 0.170 |
Why?
|
| Monosaccharides | 1 | 1999 | 23 | 0.170 |
Why?
|
| Alkenes | 1 | 1999 | 5 | 0.170 |
Why?
|
| Severity of Illness Index | 4 | 2017 | 2854 | 0.170 |
Why?
|
| Diabetic Retinopathy | 1 | 2022 | 155 | 0.170 |
Why?
|
| Administration, Oral | 4 | 2009 | 671 | 0.170 |
Why?
|
| Metagenome | 1 | 2020 | 148 | 0.170 |
Why?
|
| Infant, Newborn | 16 | 2015 | 8114 | 0.160 |
Why?
|
| Radioisotope Dilution Technique | 10 | 2000 | 43 | 0.160 |
Why?
|
| Amino Acids, Branched-Chain | 6 | 1991 | 77 | 0.160 |
Why?
|
| Fat Emulsions, Intravenous | 2 | 1991 | 72 | 0.160 |
Why?
|
| Caproates | 5 | 1992 | 6 | 0.160 |
Why?
|
| Longitudinal Studies | 2 | 2020 | 1315 | 0.160 |
Why?
|
| Wasting Syndrome | 1 | 1999 | 25 | 0.160 |
Why?
|
| Sodium Bicarbonate | 4 | 1995 | 52 | 0.160 |
Why?
|
| Registries | 2 | 2023 | 1398 | 0.150 |
Why?
|
| Hyperandrogenism | 1 | 1998 | 19 | 0.150 |
Why?
|
| Antigens, CD | 1 | 2020 | 420 | 0.150 |
Why?
|
| Prolactin | 2 | 2008 | 107 | 0.150 |
Why?
|
| Gastroenteritis | 1 | 2001 | 341 | 0.150 |
Why?
|
| Health Resources | 1 | 2019 | 115 | 0.150 |
Why?
|
| Random Allocation | 3 | 2016 | 433 | 0.150 |
Why?
|
| Carbohydrate Metabolism | 3 | 2005 | 54 | 0.150 |
Why?
|
| Infant, Premature | 4 | 2006 | 807 | 0.150 |
Why?
|
| Carbohydrates | 2 | 2014 | 33 | 0.150 |
Why?
|
| Biological Transport | 3 | 2021 | 346 | 0.150 |
Why?
|
| Drug Therapy, Combination | 7 | 2019 | 1142 | 0.140 |
Why?
|
| Isothiocyanates | 1 | 2017 | 13 | 0.140 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2002 | 309 | 0.140 |
Why?
|
| Endocrine System Diseases | 3 | 2015 | 37 | 0.140 |
Why?
|
| Threonine | 2 | 1987 | 59 | 0.140 |
Why?
|
| Beverages | 2 | 2014 | 100 | 0.140 |
Why?
|
| Sodium Chloride | 2 | 2015 | 95 | 0.140 |
Why?
|
| Overweight | 3 | 2017 | 358 | 0.140 |
Why?
|
| Triacetin | 2 | 1993 | 2 | 0.140 |
Why?
|
| Nitrogen | 5 | 1999 | 145 | 0.130 |
Why?
|
| Trypsin | 3 | 1994 | 95 | 0.130 |
Why?
|
| Carnitine | 4 | 1991 | 78 | 0.130 |
Why?
|
| Dwarfism, Pituitary | 1 | 2016 | 7 | 0.130 |
Why?
|
| Health Care Costs | 1 | 2019 | 366 | 0.130 |
Why?
|
| Ketosis | 3 | 1989 | 15 | 0.130 |
Why?
|
| Lipase | 3 | 1994 | 88 | 0.130 |
Why?
|
| Dietary Proteins | 2 | 2009 | 245 | 0.130 |
Why?
|
| Endocrinology | 2 | 2015 | 141 | 0.130 |
Why?
|
| Consensus | 2 | 2016 | 610 | 0.130 |
Why?
|
| Obesity, Morbid | 1 | 2018 | 186 | 0.130 |
Why?
|
| Ovary | 1 | 1998 | 389 | 0.120 |
Why?
|
| Young Adult | 5 | 2018 | 8867 | 0.120 |
Why?
|
| Sodium Acetate | 1 | 2015 | 2 | 0.120 |
Why?
|
| Amylases | 2 | 1994 | 26 | 0.120 |
Why?
|
| Child Development | 2 | 2013 | 260 | 0.120 |
Why?
|
| Isotonic Solutions | 1 | 2015 | 35 | 0.120 |
Why?
|
| Pancreas | 4 | 1994 | 211 | 0.120 |
Why?
|
| Community Networks | 1 | 2015 | 33 | 0.120 |
Why?
|
| Pentose Phosphate Pathway | 1 | 2015 | 43 | 0.120 |
Why?
|
| Candy | 1 | 2014 | 7 | 0.120 |
Why?
|
| Drug Delivery Systems | 1 | 2016 | 182 | 0.120 |
Why?
|
| Societies, Medical | 2 | 2015 | 678 | 0.120 |
Why?
|
| Turner Syndrome | 1 | 2015 | 47 | 0.120 |
Why?
|
| Sensitivity and Specificity | 4 | 2014 | 2019 | 0.120 |
Why?
|
| Acetoacetates | 11 | 1990 | 21 | 0.110 |
Why?
|
| Cluster Analysis | 2 | 2021 | 401 | 0.110 |
Why?
|
| Single-Blind Method | 2 | 2014 | 235 | 0.110 |
Why?
|
| Cohort Studies | 6 | 2023 | 4701 | 0.110 |
Why?
|
| Evidence-Based Practice | 1 | 2015 | 110 | 0.110 |
Why?
|
| Health Status Disparities | 1 | 2016 | 221 | 0.110 |
Why?
|
| Thinness | 1 | 2014 | 69 | 0.110 |
Why?
|
| Ketoglutaric Acids | 1 | 1993 | 24 | 0.110 |
Why?
|
| Parenteral Nutrition, Total | 2 | 2008 | 113 | 0.110 |
Why?
|
| Morbidity | 1 | 2014 | 241 | 0.110 |
Why?
|
| Analysis of Variance | 5 | 2013 | 1012 | 0.110 |
Why?
|
| Pregnancy | 7 | 2014 | 7129 | 0.110 |
Why?
|
| Hormone Replacement Therapy | 1 | 2016 | 195 | 0.110 |
Why?
|
| Receptor-Like Protein Tyrosine Phosphatases, Class 8 | 1 | 2013 | 11 | 0.110 |
Why?
|
| Viscera | 1 | 1993 | 55 | 0.110 |
Why?
|
| Incidence | 2 | 2015 | 3054 | 0.110 |
Why?
|
| Adrenocortical Hyperfunction | 2 | 1986 | 4 | 0.100 |
Why?
|
| Hydrogen-Ion Concentration | 5 | 1993 | 425 | 0.100 |
Why?
|
| Nutrition Policy | 1 | 2013 | 100 | 0.100 |
Why?
|
| Body Height | 2 | 2013 | 211 | 0.100 |
Why?
|
| Diet, High-Fat | 1 | 2014 | 212 | 0.100 |
Why?
|
| Food Deprivation | 1 | 2012 | 31 | 0.100 |
Why?
|
| Nitrogen Isotopes | 4 | 2003 | 62 | 0.100 |
Why?
|
| Hydrolysis | 3 | 2001 | 155 | 0.100 |
Why?
|
| Pancreatic Neoplasms | 4 | 1986 | 679 | 0.100 |
Why?
|
| Nutrition Assessment | 1 | 2013 | 133 | 0.100 |
Why?
|
| Prednisolone | 1 | 1992 | 72 | 0.100 |
Why?
|
| Palmitic Acid | 2 | 2010 | 35 | 0.100 |
Why?
|
| Fetal Diseases | 2 | 2015 | 440 | 0.100 |
Why?
|
| Mice | 6 | 2017 | 17556 | 0.100 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2 | 2009 | 805 | 0.090 |
Why?
|
| Glucose Clamp Technique | 5 | 2002 | 79 | 0.090 |
Why?
|
| Infusions, Parenteral | 9 | 2007 | 100 | 0.090 |
Why?
|
| Insulin Antagonists | 2 | 1991 | 4 | 0.090 |
Why?
|
| Anesthesia, General | 2 | 1990 | 112 | 0.090 |
Why?
|
| Albumins | 1 | 1991 | 88 | 0.090 |
Why?
|
| Middle Aged | 19 | 2020 | 26091 | 0.090 |
Why?
|
| Brain Diseases | 5 | 1979 | 298 | 0.090 |
Why?
|
| Sex Factors | 3 | 2013 | 1265 | 0.090 |
Why?
|
| Protein Carbonylation | 1 | 2010 | 7 | 0.090 |
Why?
|
| Patient Safety | 1 | 2015 | 397 | 0.090 |
Why?
|
| Adaptation, Physiological | 2 | 2003 | 261 | 0.090 |
Why?
|
| Infusion Pumps, Implantable | 2 | 2010 | 40 | 0.090 |
Why?
|
| Lipid Peroxidation | 1 | 2010 | 81 | 0.090 |
Why?
|
| Anti-Obesity Agents | 1 | 2010 | 42 | 0.090 |
Why?
|
| Biomarkers | 2 | 2022 | 2953 | 0.090 |
Why?
|
| Isoflurane | 1 | 1990 | 45 | 0.090 |
Why?
|
| Body Weight | 6 | 2005 | 1007 | 0.090 |
Why?
|
| Pyruvates | 8 | 1991 | 21 | 0.080 |
Why?
|
| Drug Administration Schedule | 4 | 2007 | 726 | 0.080 |
Why?
|
| Health Behavior | 1 | 2013 | 382 | 0.080 |
Why?
|
| Hexoses | 1 | 2009 | 11 | 0.080 |
Why?
|
| Mice, Inbred C57BL | 3 | 2017 | 4368 | 0.080 |
Why?
|
| Osmolar Concentration | 4 | 1998 | 176 | 0.080 |
Why?
|
| Motor Activity | 1 | 2013 | 522 | 0.080 |
Why?
|
| Chemoreceptor Cells | 1 | 2009 | 14 | 0.080 |
Why?
|
| Insulinoma | 2 | 1986 | 10 | 0.080 |
Why?
|
| Alkalosis | 1 | 1989 | 24 | 0.080 |
Why?
|
| Diabetes Mellitus, Experimental | 6 | 1990 | 135 | 0.080 |
Why?
|
| Age Factors | 4 | 2013 | 2811 | 0.080 |
Why?
|
| Glycosuria | 2 | 2007 | 6 | 0.080 |
Why?
|
| Health Expenditures | 1 | 2010 | 103 | 0.080 |
Why?
|
| Quality Improvement | 1 | 2015 | 624 | 0.080 |
Why?
|
| Diet, Diabetic | 1 | 2009 | 6 | 0.080 |
Why?
|
| Sample Size | 1 | 2009 | 85 | 0.080 |
Why?
|
| Treatment Failure | 2 | 2023 | 335 | 0.080 |
Why?
|
| History, 20th Century | 2 | 2021 | 381 | 0.080 |
Why?
|
| Halothane | 1 | 1988 | 11 | 0.080 |
Why?
|
| Nitrous Oxide | 1 | 1988 | 14 | 0.080 |
Why?
|
| Adenoma, Islet Cell | 2 | 1986 | 8 | 0.080 |
Why?
|
| Texas | 2 | 2015 | 3558 | 0.080 |
Why?
|
| Fatty Liver | 2 | 2009 | 178 | 0.080 |
Why?
|
| Calcium | 5 | 2006 | 1098 | 0.080 |
Why?
|
| Diet, Reducing | 1 | 2009 | 90 | 0.080 |
Why?
|
| Area Under Curve | 1 | 2009 | 314 | 0.080 |
Why?
|
| Maple Syrup Urine Disease | 3 | 1980 | 16 | 0.080 |
Why?
|
| Peptide Hydrolases | 2 | 1993 | 141 | 0.080 |
Why?
|
| Pancreatectomy | 4 | 1990 | 136 | 0.080 |
Why?
|
| Gastrointestinal Motility | 1 | 2008 | 45 | 0.080 |
Why?
|
| Methenamine | 1 | 2008 | 7 | 0.080 |
Why?
|
| Lung Diseases | 1 | 1992 | 378 | 0.080 |
Why?
|
| Muscular Dystrophies | 2 | 1998 | 51 | 0.070 |
Why?
|
| Circadian Rhythm | 5 | 2004 | 269 | 0.070 |
Why?
|
| Lactalbumin | 1 | 2007 | 11 | 0.070 |
Why?
|
| Somatostatin | 8 | 1993 | 71 | 0.070 |
Why?
|
| Body Water | 1 | 2008 | 89 | 0.070 |
Why?
|
| Breath Tests | 4 | 2000 | 179 | 0.070 |
Why?
|
| Exercise Therapy | 1 | 2009 | 152 | 0.070 |
Why?
|
| Mass Screening | 1 | 2013 | 787 | 0.070 |
Why?
|
| Treatment Outcome | 5 | 2019 | 12170 | 0.070 |
Why?
|
| Emetine | 1 | 1987 | 7 | 0.070 |
Why?
|
| Receptors, Cell Surface | 2 | 2009 | 469 | 0.070 |
Why?
|
| Mice, Knockout | 2 | 2012 | 3727 | 0.070 |
Why?
|
| Algorithms | 2 | 2015 | 1598 | 0.070 |
Why?
|
| Infant, Small for Gestational Age | 2 | 2002 | 49 | 0.070 |
Why?
|
| Transcriptome | 1 | 2013 | 903 | 0.070 |
Why?
|
| Hemangioendothelioma | 1 | 2007 | 25 | 0.070 |
Why?
|
| Epithelium | 1 | 2007 | 360 | 0.070 |
Why?
|
| Cell Cycle Proteins | 1 | 2011 | 645 | 0.070 |
Why?
|
| Muscles | 4 | 1991 | 288 | 0.070 |
Why?
|
| Capillaries | 1 | 2006 | 66 | 0.070 |
Why?
|
| Pregnancy, Multiple | 1 | 2006 | 50 | 0.070 |
Why?
|
| Magnesium Sulfate | 1 | 2006 | 50 | 0.070 |
Why?
|
| Adrenal Cortex Neoplasms | 1 | 1986 | 17 | 0.070 |
Why?
|
| Bone Diseases, Metabolic | 1 | 2006 | 54 | 0.070 |
Why?
|
| Pancreatic Pseudocyst | 1 | 1986 | 13 | 0.070 |
Why?
|
| Gene Regulatory Networks | 1 | 2008 | 351 | 0.060 |
Why?
|
| MicroRNAs | 1 | 2013 | 827 | 0.060 |
Why?
|
| Risk Assessment | 2 | 2013 | 3336 | 0.060 |
Why?
|
| Brain | 9 | 1991 | 2966 | 0.060 |
Why?
|
| Injections, Intravenous | 5 | 1995 | 254 | 0.060 |
Why?
|
| Cross-Sectional Studies | 3 | 2020 | 3384 | 0.060 |
Why?
|
| Acanthosis Nigricans | 1 | 1986 | 10 | 0.060 |
Why?
|
| Hypothyroidism | 1 | 2007 | 89 | 0.060 |
Why?
|
| Urea | 2 | 2003 | 223 | 0.060 |
Why?
|
| Pancreatic Cyst | 1 | 1986 | 30 | 0.060 |
Why?
|
| Metabolism, Inborn Errors | 2 | 2002 | 114 | 0.060 |
Why?
|
| Actins | 1 | 2007 | 340 | 0.060 |
Why?
|
| Glycolysis | 2 | 2005 | 146 | 0.060 |
Why?
|
| Respiration | 3 | 2003 | 122 | 0.060 |
Why?
|
| Androgens | 3 | 1998 | 274 | 0.060 |
Why?
|
| Age of Onset | 2 | 2019 | 581 | 0.060 |
Why?
|
| Anthropometry | 2 | 2018 | 198 | 0.060 |
Why?
|
| Organosilicon Compounds | 1 | 1984 | 2 | 0.060 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2007 | 1289 | 0.060 |
Why?
|
| Silicon | 1 | 1984 | 12 | 0.060 |
Why?
|
| Malignant Hyperthermia | 1 | 1984 | 19 | 0.060 |
Why?
|
| Pancreatitis | 1 | 1986 | 130 | 0.060 |
Why?
|
| Monitoring, Ambulatory | 1 | 2004 | 54 | 0.060 |
Why?
|
| Phenotype | 2 | 2013 | 4227 | 0.060 |
Why?
|
| Gastric Inhibitory Polypeptide | 2 | 2020 | 19 | 0.060 |
Why?
|
| RNA | 1 | 2007 | 568 | 0.060 |
Why?
|
| Intubation, Gastrointestinal | 2 | 1995 | 52 | 0.060 |
Why?
|
| Sex Characteristics | 2 | 2003 | 314 | 0.060 |
Why?
|
| Bone and Bones | 2 | 2006 | 263 | 0.060 |
Why?
|
| Software | 1 | 2008 | 675 | 0.060 |
Why?
|
| Adipocytes | 1 | 2005 | 158 | 0.060 |
Why?
|
| Insulin Glargine | 2 | 2019 | 8 | 0.060 |
Why?
|
| Prognosis | 1 | 2013 | 4511 | 0.060 |
Why?
|
| Biology | 1 | 2024 | 29 | 0.060 |
Why?
|
| Cell Proliferation | 1 | 2011 | 2314 | 0.050 |
Why?
|
| Albuminuria | 1 | 2023 | 92 | 0.050 |
Why?
|
| Carbohydrate Metabolism, Inborn Errors | 3 | 1999 | 36 | 0.050 |
Why?
|
| Risk Factors | 3 | 2023 | 10035 | 0.050 |
Why?
|
| Glomerular Filtration Rate | 2 | 2023 | 482 | 0.050 |
Why?
|
| Adenoma | 1 | 1984 | 134 | 0.050 |
Why?
|
| Glucosamine | 1 | 1982 | 12 | 0.050 |
Why?
|
| Transcription, Genetic | 1 | 2007 | 1701 | 0.050 |
Why?
|
| Bicarbonates | 5 | 1996 | 98 | 0.050 |
Why?
|
| Glycosyltransferases | 1 | 2022 | 25 | 0.050 |
Why?
|
| Life Style | 2 | 2016 | 406 | 0.050 |
Why?
|
| Radiation Dosage | 1 | 1982 | 134 | 0.050 |
Why?
|
| Hospitalization | 1 | 2010 | 1737 | 0.050 |
Why?
|
| Enteral Nutrition | 3 | 1996 | 251 | 0.050 |
Why?
|
| Testosterone | 2 | 1994 | 532 | 0.050 |
Why?
|
| Norepinephrine | 8 | 1993 | 174 | 0.050 |
Why?
|
| Multiple Endocrine Neoplasia | 3 | 1986 | 12 | 0.050 |
Why?
|
| Growth Substances | 1 | 2002 | 113 | 0.050 |
Why?
|
| Patient Compliance | 2 | 2019 | 469 | 0.050 |
Why?
|
| Fucosyltransferases | 1 | 2021 | 29 | 0.050 |
Why?
|
| Research Design | 2 | 2016 | 679 | 0.050 |
Why?
|
| Growth | 1 | 2002 | 106 | 0.050 |
Why?
|
| Glycosylation | 1 | 2021 | 115 | 0.050 |
Why?
|
| Mucins | 1 | 2021 | 74 | 0.050 |
Why?
|
| Oxygen | 1 | 2005 | 550 | 0.050 |
Why?
|
| Metabolic Clearance Rate | 6 | 2003 | 142 | 0.050 |
Why?
|
| Retrospective Studies | 3 | 2015 | 16069 | 0.050 |
Why?
|
| Prevalence | 2 | 2008 | 2409 | 0.050 |
Why?
|
| Glucose Solution, Hypertonic | 2 | 1978 | 2 | 0.050 |
Why?
|
| Adrenocorticotropic Hormone | 2 | 1983 | 77 | 0.050 |
Why?
|
| Gene Knockout Techniques | 1 | 2021 | 125 | 0.050 |
Why?
|
| Safety | 1 | 2002 | 218 | 0.050 |
Why?
|
| Ultrasonography | 1 | 1986 | 942 | 0.050 |
Why?
|
| Splanchnic Circulation | 2 | 1995 | 52 | 0.050 |
Why?
|
| History, 18th Century | 2 | 2000 | 69 | 0.050 |
Why?
|
| Water | 1 | 2002 | 182 | 0.040 |
Why?
|
| Gangliosides | 1 | 2021 | 69 | 0.040 |
Why?
|
| Erythropoietin | 1 | 2021 | 104 | 0.040 |
Why?
|
| Peptide YY | 1 | 2020 | 19 | 0.040 |
Why?
|
| Postpartum Period | 1 | 2002 | 214 | 0.040 |
Why?
|
| Follow-Up Studies | 2 | 2023 | 5056 | 0.040 |
Why?
|
| Glucagon-Like Peptide 1 | 1 | 2020 | 68 | 0.040 |
Why?
|
| Hirsutism | 1 | 1979 | 20 | 0.040 |
Why?
|
| History, 19th Century | 1 | 2000 | 116 | 0.040 |
Why?
|
| Indicators and Reagents | 1 | 1999 | 51 | 0.040 |
Why?
|
| Chromatography, Ion Exchange | 2 | 1993 | 68 | 0.040 |
Why?
|
| Infusion Pumps | 2 | 1997 | 33 | 0.040 |
Why?
|
| Muscular Dystrophy, Duchenne | 1 | 1999 | 64 | 0.040 |
Why?
|
| Phosphates | 2 | 1978 | 111 | 0.040 |
Why?
|
| Immunocompetence | 1 | 1999 | 33 | 0.040 |
Why?
|
| Drug Costs | 1 | 2019 | 60 | 0.040 |
Why?
|
| Exome | 1 | 2024 | 1040 | 0.040 |
Why?
|
| Sex Chromosomes | 1 | 1978 | 34 | 0.040 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 1984 | 532 | 0.040 |
Why?
|
| Hypoparathyroidism | 1 | 1978 | 11 | 0.040 |
Why?
|
| Cholesterol, LDL | 1 | 2022 | 560 | 0.040 |
Why?
|
| Consciousness | 2 | 1989 | 49 | 0.040 |
Why?
|
| Nutritional Status | 1 | 2020 | 305 | 0.040 |
Why?
|
| Costs and Cost Analysis | 1 | 2019 | 164 | 0.040 |
Why?
|
| Ethinyl Estradiol-Norgestrel Combination | 1 | 1998 | 2 | 0.040 |
Why?
|
| Case-Control Studies | 3 | 2020 | 3239 | 0.040 |
Why?
|
| Basal Metabolism | 4 | 1996 | 93 | 0.040 |
Why?
|
| Infant, Low Birth Weight | 1 | 1999 | 167 | 0.040 |
Why?
|
| Liver Transplantation | 1 | 2007 | 1022 | 0.040 |
Why?
|
| Clitoris | 1 | 1977 | 3 | 0.040 |
Why?
|
| Steroid Hydroxylases | 1 | 1977 | 20 | 0.040 |
Why?
|
| Risk Reduction Behavior | 1 | 2019 | 139 | 0.040 |
Why?
|
| Vulva | 1 | 1977 | 16 | 0.040 |
Why?
|
| Hepatocyte Nuclear Factor 1-alpha | 1 | 2017 | 14 | 0.040 |
Why?
|
| Hepatocyte Nuclear Factor 4 | 1 | 2017 | 19 | 0.040 |
Why?
|
| Cyclic AMP | 1 | 1978 | 248 | 0.040 |
Why?
|
| X Chromosome | 1 | 1978 | 337 | 0.040 |
Why?
|
| Calorimetry | 2 | 2003 | 57 | 0.040 |
Why?
|
| Sulfoxides | 1 | 2017 | 10 | 0.040 |
Why?
|
| Disorders of Sex Development | 2 | 1980 | 78 | 0.040 |
Why?
|
| Pilot Projects | 1 | 2002 | 1389 | 0.040 |
Why?
|
| Lipid Metabolism, Inborn Errors | 2 | 1991 | 19 | 0.040 |
Why?
|
| Self Care | 1 | 2019 | 213 | 0.040 |
Why?
|
| Insulin-Like Growth Factor Binding Proteins | 1 | 1997 | 31 | 0.040 |
Why?
|
| Lipodystrophy, Congenital Generalized | 1 | 2017 | 5 | 0.040 |
Why?
|
| Insulin-Like Growth Factor II | 1 | 1997 | 41 | 0.030 |
Why?
|
| Disease Progression | 1 | 2023 | 2030 | 0.030 |
Why?
|
| Diabetes Complications | 1 | 2018 | 196 | 0.030 |
Why?
|
| HIV-Associated Lipodystrophy Syndrome | 1 | 2017 | 28 | 0.030 |
Why?
|
| Drug Interactions | 4 | 1993 | 253 | 0.030 |
Why?
|
| Genome-Wide Association Study | 1 | 2024 | 1637 | 0.030 |
Why?
|
| Genetic Variation | 1 | 2023 | 1479 | 0.030 |
Why?
|
| Drug-Related Side Effects and Adverse Reactions | 1 | 2019 | 256 | 0.030 |
Why?
|
| Liver Neoplasms | 1 | 2007 | 1312 | 0.030 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2017 | 102 | 0.030 |
Why?
|
| Hypopituitarism | 1 | 1976 | 16 | 0.030 |
Why?
|
| Adiponectin | 1 | 2016 | 109 | 0.030 |
Why?
|
| Birth Weight | 3 | 1974 | 339 | 0.030 |
Why?
|
| Thiazoles | 1 | 2016 | 97 | 0.030 |
Why?
|
| Absorptiometry, Photon | 2 | 2009 | 179 | 0.030 |
Why?
|
| Pediatrics | 2 | 2015 | 1141 | 0.030 |
Why?
|
| Protein Deficiency | 1 | 1996 | 20 | 0.030 |
Why?
|
| Neurosecretory Systems | 1 | 1996 | 23 | 0.030 |
Why?
|
| Epilepsy | 1 | 1983 | 858 | 0.030 |
Why?
|
| Phentolamine | 6 | 1980 | 20 | 0.030 |
Why?
|
| Drug Combinations | 1 | 2016 | 268 | 0.030 |
Why?
|
| Microbiota | 1 | 2020 | 391 | 0.030 |
Why?
|
| Chromosome Aberrations | 1 | 1978 | 620 | 0.030 |
Why?
|
| Nutritional Support | 1 | 1996 | 51 | 0.030 |
Why?
|
| Oxygen Consumption | 2 | 2009 | 307 | 0.030 |
Why?
|
| Gonadal Steroid Hormones | 1 | 1996 | 87 | 0.030 |
Why?
|
| Education | 1 | 2015 | 105 | 0.030 |
Why?
|
| Propranolol | 6 | 1980 | 128 | 0.030 |
Why?
|
| Estrogen Replacement Therapy | 1 | 2015 | 44 | 0.030 |
Why?
|
| Molecular Structure | 1 | 1995 | 284 | 0.030 |
Why?
|
| Europe | 1 | 2015 | 349 | 0.030 |
Why?
|
| Clinical Trials as Topic | 2 | 2016 | 1084 | 0.030 |
Why?
|
| Jejunostomy | 1 | 1994 | 20 | 0.030 |
Why?
|
| Octreotide | 1 | 1994 | 21 | 0.030 |
Why?
|
| Sincalide | 1 | 1994 | 4 | 0.030 |
Why?
|
| Dexamethasone | 3 | 2009 | 271 | 0.030 |
Why?
|
| Adipates | 1 | 1993 | 1 | 0.030 |
Why?
|
| Adipokines | 1 | 2014 | 58 | 0.030 |
Why?
|
| Chromatography, Thin Layer | 1 | 1993 | 41 | 0.030 |
Why?
|
| Catecholamines | 2 | 1991 | 58 | 0.030 |
Why?
|
| Isotopes | 1 | 1993 | 27 | 0.030 |
Why?
|
| Parents | 1 | 2001 | 1032 | 0.030 |
Why?
|
| United States | 2 | 2013 | 10654 | 0.030 |
Why?
|
| Caregivers | 1 | 2019 | 571 | 0.030 |
Why?
|
| Proinsulin | 1 | 1993 | 12 | 0.030 |
Why?
|
| Arginine | 6 | 1990 | 331 | 0.030 |
Why?
|
| Heart Defects, Congenital | 2 | 1989 | 1803 | 0.030 |
Why?
|
| Erythrocytes | 3 | 1989 | 206 | 0.030 |
Why?
|
| Organ Size | 2 | 1984 | 419 | 0.030 |
Why?
|
| Rare Diseases | 1 | 2015 | 185 | 0.030 |
Why?
|
| Diet Therapy | 1 | 1973 | 42 | 0.030 |
Why?
|
| Mathematics | 2 | 1990 | 99 | 0.030 |
Why?
|
| Heart Rate | 4 | 2009 | 587 | 0.030 |
Why?
|
| Anemia, Sickle Cell | 1 | 1996 | 334 | 0.030 |
Why?
|
| Mice, Obese | 1 | 2012 | 78 | 0.020 |
Why?
|
| Duodenum | 1 | 1992 | 98 | 0.020 |
Why?
|
| Cell Line | 1 | 2017 | 2771 | 0.020 |
Why?
|
| Coma | 1 | 1991 | 55 | 0.020 |
Why?
|
| Cortisone | 3 | 1983 | 11 | 0.020 |
Why?
|
| Sodium | 2 | 1990 | 294 | 0.020 |
Why?
|
| Fruit | 1 | 2013 | 221 | 0.020 |
Why?
|
| Physical Exertion | 2 | 1990 | 81 | 0.020 |
Why?
|
| Mutation | 1 | 2005 | 5765 | 0.020 |
Why?
|
| Nutrition Surveys | 1 | 2013 | 290 | 0.020 |
Why?
|
| Home Care Services | 2 | 1989 | 67 | 0.020 |
Why?
|
| Splenectomy | 1 | 1991 | 60 | 0.020 |
Why?
|
| Risk | 1 | 2013 | 747 | 0.020 |
Why?
|
| Vegetables | 1 | 2013 | 261 | 0.020 |
Why?
|
| Biological Availability | 1 | 1991 | 133 | 0.020 |
Why?
|
| Radiography | 2 | 2006 | 822 | 0.020 |
Why?
|
| Adrenal Cortex Hormones | 2 | 1992 | 316 | 0.020 |
Why?
|
| Acid-Base Equilibrium | 1 | 1990 | 59 | 0.020 |
Why?
|
| Intestinal Absorption | 1 | 1991 | 190 | 0.020 |
Why?
|
| Health Services | 1 | 2010 | 71 | 0.020 |
Why?
|
| Pancreatic Hormones | 1 | 1989 | 4 | 0.020 |
Why?
|
| Methylhistidines | 1 | 1989 | 10 | 0.020 |
Why?
|
| Body Temperature | 1 | 1990 | 113 | 0.020 |
Why?
|
| Thyrotropin | 2 | 2007 | 60 | 0.020 |
Why?
|
| Spectrophotometry, Ultraviolet | 1 | 1989 | 44 | 0.020 |
Why?
|
| Triiodothyronine | 2 | 2007 | 64 | 0.020 |
Why?
|
| Metabolome | 1 | 2012 | 294 | 0.020 |
Why?
|
| Scintillation Counting | 1 | 1989 | 6 | 0.020 |
Why?
|
| Hydrochloric Acid | 1 | 1989 | 14 | 0.020 |
Why?
|
| Water-Electrolyte Balance | 2 | 1994 | 76 | 0.020 |
Why?
|
| Thyroxine | 2 | 2007 | 66 | 0.020 |
Why?
|
| Infusions, Intra-Arterial | 1 | 1989 | 27 | 0.020 |
Why?
|
| Daunorubicin | 1 | 2009 | 27 | 0.020 |
Why?
|
| Estrogens | 2 | 1996 | 512 | 0.020 |
Why?
|
| Intra-Abdominal Fat | 1 | 2009 | 51 | 0.020 |
Why?
|
| Asparaginase | 1 | 2009 | 41 | 0.020 |
Why?
|
| Blood Gas Analysis | 1 | 1989 | 82 | 0.020 |
Why?
|
| Salicylates | 1 | 1989 | 53 | 0.020 |
Why?
|
| Ovarian Neoplasms | 1 | 1973 | 409 | 0.020 |
Why?
|
| Pregnancy Complications | 2 | 1973 | 504 | 0.020 |
Why?
|
| Heparin | 3 | 1986 | 227 | 0.020 |
Why?
|
| Tissue Distribution | 1 | 1989 | 383 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2013 | 1601 | 0.020 |
Why?
|
| Exercise Tolerance | 1 | 2009 | 77 | 0.020 |
Why?
|
| Gene Deletion | 1 | 2012 | 792 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2010 | 772 | 0.020 |
Why?
|
| Acyl-CoA Dehydrogenase | 1 | 1988 | 2 | 0.020 |
Why?
|
| Fatty Acid Desaturases | 1 | 1988 | 9 | 0.020 |
Why?
|
| Cytokines | 1 | 2014 | 1282 | 0.020 |
Why?
|
| Molecular Weight | 1 | 1988 | 392 | 0.020 |
Why?
|
| Vincristine | 1 | 2009 | 196 | 0.020 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2009 | 289 | 0.020 |
Why?
|
| Insulin Antibodies | 2 | 1984 | 7 | 0.020 |
Why?
|
| Logistic Models | 1 | 2013 | 1801 | 0.020 |
Why?
|
| Liver Function Tests | 1 | 1988 | 101 | 0.020 |
Why?
|
| Remission Induction | 1 | 2008 | 299 | 0.020 |
Why?
|
| Luteinizing Hormone | 2 | 1996 | 132 | 0.020 |
Why?
|
| Ethanol | 1 | 1989 | 161 | 0.020 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2013 | 862 | 0.020 |
Why?
|
| Insulin, Long-Acting | 2 | 2004 | 5 | 0.020 |
Why?
|
| Models, Theoretical | 1 | 1989 | 356 | 0.020 |
Why?
|
| Lipid Mobilization | 1 | 1987 | 3 | 0.020 |
Why?
|
| Exercise | 1 | 1993 | 814 | 0.020 |
Why?
|
| Forearm | 1 | 1987 | 44 | 0.020 |
Why?
|
| Cardiomyopathies | 1 | 1991 | 478 | 0.020 |
Why?
|
| Demography | 1 | 1987 | 239 | 0.020 |
Why?
|
| Glycine | 2 | 1996 | 169 | 0.020 |
Why?
|
| Feminization | 1 | 1986 | 3 | 0.020 |
Why?
|
| Absorption | 1 | 1986 | 52 | 0.020 |
Why?
|
| Hindlimb | 2 | 1990 | 75 | 0.020 |
Why?
|
| Hyperaldosteronism | 1 | 1986 | 15 | 0.020 |
Why?
|
| Alkaline Phosphatase | 1 | 2006 | 98 | 0.020 |
Why?
|
| Herpes Simplex | 2 | 1981 | 56 | 0.020 |
Why?
|
| Cushing Syndrome | 1 | 1986 | 17 | 0.020 |
Why?
|
| Calcitriol | 1 | 2006 | 81 | 0.020 |
Why?
|
| Magnesium | 1 | 2006 | 121 | 0.020 |
Why?
|
| Sympathetic Nervous System | 2 | 1976 | 62 | 0.020 |
Why?
|
| Acromegaly | 1 | 1986 | 8 | 0.020 |
Why?
|
| Adrenalectomy | 1 | 1986 | 36 | 0.020 |
Why?
|
| Bone Density Conservation Agents | 1 | 2006 | 52 | 0.020 |
Why?
|
| Hyperprolactinemia | 1 | 1986 | 17 | 0.020 |
Why?
|
| Niacin | 1 | 1986 | 57 | 0.020 |
Why?
|
| Intraoperative Care | 1 | 1986 | 103 | 0.020 |
Why?
|
| Phosphorus | 2 | 1975 | 56 | 0.020 |
Why?
|
| Diseases in Twins | 1 | 1986 | 94 | 0.020 |
Why?
|
| Hyperthyroidism | 1 | 1985 | 26 | 0.020 |
Why?
|
| Insulin Lispro | 1 | 2004 | 2 | 0.020 |
Why?
|
| Insulin Aspart | 1 | 2004 | 2 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2009 | 3549 | 0.010 |
Why?
|
| Ethers, Cyclic | 1 | 1984 | 14 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2010 | 2114 | 0.010 |
Why?
|
| Glucosephosphates | 1 | 1984 | 2 | 0.010 |
Why?
|
| Glucose-6-Phosphate | 1 | 1984 | 3 | 0.010 |
Why?
|
| Epoxy Compounds | 1 | 1984 | 18 | 0.010 |
Why?
|
| Propionates | 1 | 1984 | 30 | 0.010 |
Why?
|
| Palmitates | 3 | 1989 | 19 | 0.010 |
Why?
|
| Granulocytes | 1 | 1984 | 65 | 0.010 |
Why?
|
| Injections | 1 | 2004 | 153 | 0.010 |
Why?
|
| Dehydration | 1 | 1983 | 37 | 0.010 |
Why?
|
| Electrolytes | 1 | 1983 | 51 | 0.010 |
Why?
|
| Escherichia coli | 1 | 2009 | 982 | 0.010 |
Why?
|
| Microchemistry | 1 | 1983 | 7 | 0.010 |
Why?
|
| Virus Diseases | 2 | 1976 | 279 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2009 | 1118 | 0.010 |
Why?
|
| Chemistry | 1 | 1982 | 60 | 0.010 |
Why?
|
| Surveys and Questionnaires | 1 | 2013 | 3677 | 0.010 |
Why?
|
| Chemical Phenomena | 1 | 1982 | 85 | 0.010 |
Why?
|
| Spectrometry, Fluorescence | 1 | 1983 | 87 | 0.010 |
Why?
|
| Pancreatic Polypeptide | 1 | 1982 | 7 | 0.010 |
Why?
|
| Physical Fitness | 1 | 2003 | 91 | 0.010 |
Why?
|
| Theophylline | 1 | 1982 | 29 | 0.010 |
Why?
|
| Recurrence | 1 | 1986 | 1418 | 0.010 |
Why?
|
| Serum Globulins | 1 | 1982 | 6 | 0.010 |
Why?
|
| Pedigree | 1 | 1986 | 1577 | 0.010 |
Why?
|
| Carboxylic Acids | 1 | 1982 | 24 | 0.010 |
Why?
|
| Binding, Competitive | 1 | 1982 | 183 | 0.010 |
Why?
|
| Adrenergic alpha-Antagonists | 1 | 1980 | 47 | 0.010 |
Why?
|
| Electronics, Medical | 1 | 1980 | 9 | 0.010 |
Why?
|
| Carbon | 1 | 1980 | 92 | 0.010 |
Why?
|
| Receptors, Adrenergic | 1 | 1980 | 29 | 0.010 |
Why?
|
| Pyruvate Dehydrogenase Complex Deficiency Disease | 1 | 1979 | 4 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 1983 | 1238 | 0.010 |
Why?
|
| Norethynodrel | 1 | 1979 | 1 | 0.010 |
Why?
|
| Mestranol | 1 | 1979 | 2 | 0.010 |
Why?
|
| Receptors, Adrenergic, beta | 1 | 1980 | 58 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 2009 | 1663 | 0.010 |
Why?
|
| Chimera | 1 | 1980 | 87 | 0.010 |
Why?
|
| Sex Hormone-Binding Globulin | 1 | 1979 | 38 | 0.010 |
Why?
|
| Mitochondria | 2 | 1991 | 676 | 0.010 |
Why?
|
| Bone Development | 2 | 1996 | 56 | 0.010 |
Why?
|
| Follicle Stimulating Hormone | 1 | 1979 | 197 | 0.010 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 1980 | 233 | 0.010 |
Why?
|
| Rickets | 1 | 1978 | 9 | 0.010 |
Why?
|
| Polycystic Ovary Syndrome | 1 | 1979 | 59 | 0.010 |
Why?
|
| Muscle Proteins | 1 | 1982 | 418 | 0.010 |
Why?
|
| Citric Acid Cycle | 2 | 1977 | 47 | 0.010 |
Why?
|
| Parathyroid Hormone | 1 | 1978 | 72 | 0.010 |
Why?
|
| Indicator Dilution Techniques | 1 | 1998 | 24 | 0.010 |
Why?
|
| Pyruvate Carboxylase Deficiency Disease | 1 | 1977 | 2 | 0.010 |
Why?
|
| Blood | 2 | 1976 | 105 | 0.010 |
Why?
|
| Vulvar Diseases | 1 | 1977 | 11 | 0.010 |
Why?
|
| In Vitro Techniques | 4 | 1984 | 967 | 0.010 |
Why?
|
| Protein Binding | 1 | 1982 | 1741 | 0.010 |
Why?
|
| Bone Diseases | 1 | 1977 | 45 | 0.010 |
Why?
|
| Neurotransmitter Agents | 1 | 1978 | 145 | 0.010 |
Why?
|
| Sympatholytics | 1 | 1976 | 4 | 0.010 |
Why?
|
| Reticulocytes | 1 | 1996 | 42 | 0.010 |
Why?
|
| Adrenergic alpha-Agonists | 1 | 1976 | 22 | 0.010 |
Why?
|
| Mitochondria, Liver | 1 | 1976 | 31 | 0.010 |
Why?
|
| Acetates | 2 | 1991 | 71 | 0.010 |
Why?
|
| Hormones, Ectopic | 1 | 1976 | 10 | 0.010 |
Why?
|
| Vasopressins | 1 | 1976 | 43 | 0.010 |
Why?
|
| Pituitary Gland | 1 | 1976 | 86 | 0.010 |
Why?
|
| Maternal-Fetal Exchange | 2 | 1973 | 80 | 0.010 |
Why?
|
| Sexual Maturation | 1 | 1996 | 48 | 0.010 |
Why?
|
| Acid-Base Imbalance | 1 | 1975 | 27 | 0.010 |
Why?
|
| Mannitol | 1 | 1975 | 48 | 0.010 |
Why?
|
| Fibroblasts | 3 | 1991 | 884 | 0.010 |
Why?
|
| Gonadotropin-Releasing Hormone | 1 | 1996 | 90 | 0.010 |
Why?
|
| Levodopa | 1 | 1975 | 91 | 0.010 |
Why?
|
| Encephalomalacia | 1 | 1975 | 4 | 0.010 |
Why?
|
| Streptozocin | 1 | 1975 | 24 | 0.010 |
Why?
|
| Hyponatremia | 1 | 1976 | 72 | 0.010 |
Why?
|
| Water-Electrolyte Imbalance | 1 | 1976 | 77 | 0.010 |
Why?
|
| Parenteral Nutrition, Home | 1 | 1994 | 7 | 0.010 |
Why?
|
| Gastrointestinal Hormones | 1 | 1994 | 21 | 0.010 |
Why?
|
| Gastric Acid | 1 | 1994 | 50 | 0.010 |
Why?
|
| Delayed-Action Preparations | 1 | 1994 | 110 | 0.010 |
Why?
|
| Umbilical Cord | 1 | 1974 | 55 | 0.010 |
Why?
|
| Brain Stem | 1 | 1975 | 115 | 0.010 |
Why?
|
| Short Bowel Syndrome | 1 | 1994 | 61 | 0.010 |
Why?
|
| Veins | 1 | 1974 | 106 | 0.010 |
Why?
|
| Glutamate Dehydrogenase | 1 | 1973 | 2 | 0.010 |
Why?
|
| Pregnanetriol | 1 | 1973 | 1 | 0.010 |
Why?
|
| 17-Ketosteroids | 1 | 1973 | 4 | 0.010 |
Why?
|
| Chromatography | 1 | 1973 | 43 | 0.010 |
Why?
|
| Virilism | 1 | 1973 | 14 | 0.010 |
Why?
|
| Acute Disease | 1 | 1976 | 1093 | 0.010 |
Why?
|
| Dihydroxyphenylalanine | 1 | 1973 | 8 | 0.010 |
Why?
|
| Gestational Age | 2 | 1974 | 1137 | 0.010 |
Why?
|
| Glutamates | 1 | 1973 | 69 | 0.010 |
Why?
|
| Monocytes | 2 | 1986 | 345 | 0.010 |
Why?
|
| Karyotyping | 1 | 1973 | 330 | 0.010 |
Why?
|
| Abnormalities, Multiple | 1 | 1978 | 962 | 0.010 |
Why?
|
| Hemodynamics | 1 | 1976 | 843 | 0.010 |
Why?
|
| Intubation, Intratracheal | 1 | 1975 | 291 | 0.010 |
Why?
|
| Alloxan | 2 | 1982 | 3 | 0.010 |
Why?
|
| Palmitic Acids | 1 | 1991 | 14 | 0.010 |
Why?
|
| Dwarfism | 1 | 1973 | 101 | 0.010 |
Why?
|
| Idoxuridine | 1 | 1971 | 6 | 0.010 |
Why?
|
| Portal System | 1 | 1991 | 32 | 0.010 |
Why?
|
| Floxuridine | 1 | 1971 | 9 | 0.010 |
Why?
|
| Pulse | 2 | 1985 | 31 | 0.010 |
Why?
|
| Portal Vein | 2 | 1982 | 91 | 0.010 |
Why?
|
| Genes, Recessive | 1 | 1991 | 179 | 0.010 |
Why?
|
| Smoking | 1 | 1976 | 1031 | 0.010 |
Why?
|
| Ammonium Chloride | 1 | 1990 | 7 | 0.010 |
Why?
|
| Infant, Newborn, Diseases | 1 | 1973 | 170 | 0.010 |
Why?
|
| Infant, Premature, Diseases | 1 | 1973 | 239 | 0.010 |
Why?
|
| Liver Circulation | 1 | 1990 | 24 | 0.010 |
Why?
|
| Leukocytes | 1 | 1991 | 206 | 0.010 |
Why?
|
| Blood Pressure | 3 | 1984 | 1326 | 0.010 |
Why?
|
| Encephalitis | 1 | 1971 | 109 | 0.010 |
Why?
|
| Perfusion | 3 | 1975 | 200 | 0.010 |
Why?
|
| Tyrosine | 1 | 1970 | 152 | 0.010 |
Why?
|
| Periodicity | 1 | 1969 | 55 | 0.010 |
Why?
|
| Cytomegalovirus Infections | 1 | 1971 | 217 | 0.010 |
Why?
|
| Intestinal Mucosa | 1 | 1994 | 780 | 0.010 |
Why?
|
| Aged | 4 | 1994 | 19198 | 0.000 |
Why?
|
| Biopsy, Needle | 1 | 1988 | 229 | 0.000 |
Why?
|
| Pneumococcal Infections | 1 | 1969 | 274 | 0.000 |
Why?
|
| Cells, Cultured | 1 | 1991 | 3044 | 0.000 |
Why?
|
| Syndrome | 2 | 1979 | 1116 | 0.000 |
Why?
|
| Rats | 3 | 1975 | 3666 | 0.000 |
Why?
|
| Binding Sites | 1 | 1986 | 1291 | 0.000 |
Why?
|
| Injections, Intraperitoneal | 1 | 1982 | 73 | 0.000 |
Why?
|
| Peripheral Nerves | 1 | 1982 | 85 | 0.000 |
Why?
|
| Autopsy | 1 | 1981 | 110 | 0.000 |
Why?
|
| Kidd Blood-Group System | 1 | 1980 | 1 | 0.000 |
Why?
|
| Inulin | 1 | 1980 | 17 | 0.000 |
Why?
|
| Decarboxylation | 1 | 1979 | 3 | 0.000 |
Why?
|
| Dichloroacetic Acid | 1 | 1979 | 11 | 0.000 |
Why?
|
| Sex Chromosome Aberrations | 1 | 1980 | 56 | 0.000 |
Why?
|
| Fertilization | 1 | 1980 | 43 | 0.000 |
Why?
|
| Meiosis | 1 | 1980 | 115 | 0.000 |
Why?
|
| Functional Laterality | 1 | 1980 | 181 | 0.000 |
Why?
|
| Necrosis | 1 | 1979 | 205 | 0.000 |
Why?
|
| Enzyme Activation | 1 | 1979 | 619 | 0.000 |
Why?
|
| Coenzyme A | 1 | 1977 | 5 | 0.000 |
Why?
|
| Chromatography, Gas | 1 | 1977 | 30 | 0.000 |
Why?
|
| Citrates | 1 | 1977 | 22 | 0.000 |
Why?
|
| Vasoconstriction | 1 | 1978 | 104 | 0.000 |
Why?
|
| Posture | 1 | 1978 | 152 | 0.000 |
Why?
|
| Mass Spectrometry | 1 | 1977 | 329 | 0.000 |
Why?
|
| Central Nervous System | 1 | 1977 | 253 | 0.000 |
Why?
|
| Microbial Collagenase | 1 | 1975 | 12 | 0.000 |
Why?
|
| Complement Fixation Tests | 1 | 1975 | 33 | 0.000 |
Why?
|
| Phosphorylation | 1 | 1979 | 1613 | 0.000 |
Why?
|
| Glyceraldehyde | 1 | 1975 | 28 | 0.000 |
Why?
|
| Missouri | 1 | 1975 | 36 | 0.000 |
Why?
|
| Chickenpox | 1 | 1975 | 20 | 0.000 |
Why?
|
| Receptors, Drug | 1 | 1975 | 38 | 0.000 |
Why?
|
| Spermine Synthase | 1 | 1975 | 2 | 0.000 |
Why?
|
| Paramyxoviridae Infections | 1 | 1975 | 45 | 0.000 |
Why?
|
| Adenoviridae Infections | 1 | 1975 | 70 | 0.000 |
Why?
|
| Stereoisomerism | 1 | 1975 | 103 | 0.000 |
Why?
|
| Drug Synergism | 1 | 1975 | 239 | 0.000 |
Why?
|
| Respiratory Syncytial Viruses | 1 | 1975 | 145 | 0.000 |
Why?
|
| Cerebral Angiography | 1 | 1975 | 102 | 0.000 |
Why?
|
| Synapses | 1 | 1978 | 445 | 0.000 |
Why?
|
| Genes, Dominant | 1 | 1975 | 251 | 0.000 |
Why?
|
| Viruses | 1 | 1975 | 123 | 0.000 |
Why?
|
| Structure-Activity Relationship | 1 | 1975 | 569 | 0.000 |
Why?
|
| Glycogen Synthase | 1 | 1973 | 5 | 0.000 |
Why?
|
| Diazoxide | 1 | 1973 | 8 | 0.000 |
Why?
|
| Glucose-6-Phosphatase | 1 | 1973 | 17 | 0.000 |
Why?
|
| Glycoside Hydrolases | 1 | 1973 | 17 | 0.000 |
Why?
|
| Galactosemias | 1 | 1973 | 14 | 0.000 |
Why?
|
| Adrenal Gland Diseases | 1 | 1973 | 13 | 0.000 |
Why?
|
| Liver Glycogen | 1 | 1973 | 23 | 0.000 |
Why?
|
| Glucosyltransferases | 1 | 1973 | 44 | 0.000 |
Why?
|
| Pancreatic Diseases | 1 | 1973 | 39 | 0.000 |
Why?
|
| Infant Food | 1 | 1973 | 81 | 0.000 |
Why?
|
| Hyperplasia | 1 | 1973 | 209 | 0.000 |
Why?
|
| Enzyme Inhibitors | 1 | 1975 | 576 | 0.000 |
Why?
|
| Inclusion Bodies, Viral | 1 | 1971 | 11 | 0.000 |
Why?
|
| Urine | 1 | 1971 | 89 | 0.000 |
Why?
|
| Cerebrospinal Fluid | 1 | 1971 | 93 | 0.000 |
Why?
|
| Microscopy, Electron | 1 | 1971 | 391 | 0.000 |
Why?
|
| Saliva | 1 | 1971 | 113 | 0.000 |
Why?
|
| Cytomegalovirus | 1 | 1971 | 269 | 0.000 |
Why?
|
| Pneumonia, Viral | 1 | 1975 | 373 | 0.000 |
Why?
|
| Virulence | 1 | 1969 | 261 | 0.000 |
Why?
|
| Influenza, Human | 1 | 1975 | 652 | 0.000 |
Why?
|
| Statistics as Topic | 1 | 1969 | 251 | 0.000 |
Why?
|